Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge. Issue 19 (2nd May 2017)

• Record Type: Journal Article
• Authors: Pal, Sukumar; Favaroni, Alison; Tifrea, Delia F.; Hanisch, Philipp T.; Luczak, Sören E.T.; Hegemann, Johannes H.; de la Maza, Luis M.
• Is Part Of: Vaccine. Volume 35:Issue 19(2017)
• Page Start: 2543
• Page End: 2549
• Publication Date: 2017-05-02
• Subjects: C. trachomatis -- Polymorphic membrane proteins (Pmps) -- Vaccine -- C. muridarum -- PmpC; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2017.03.070
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: Objectives: To test vaccines, formulated with novel antigens, to protect mice against Chlamydia infections. Methods: To determine the ability of polymorphic membrane proteins (Pmps) to induce cross-species protective immune responses, recombinant fragments from all nine C. trachomatis serovar E Pmps were used to vaccinate BALB/c mice utilizing CpG-1826 and Montanide ISA 720 as adjuvants. C. muridarum recombinant MOMP and PBS, formulated with the same adjuvants, were used as positive and negative controls, respectively. Mice were challenged intranasally with 10 4 inclusion-forming units (IFU) of C. muridarum . Animals were weighed daily and at 10 days post-challenge, they were euthanized, their lungs harvested, weighed and the number of chlamydial IFU counted. Results: Following vaccination the nine Pmps elicited immune responses. Based on body weight changes, or number of IFU recovered from lungs, mice vaccinated with Pmp C, G or H were the best protected. For example, over the 10-day period, the negative control group vaccinated with PBS lost significantly more body weight than mice immunized with PmpC or G (P < 0.05). C. muridarum MOMP vaccinated mice were better protected against body weight losses than any group immunized with Pmps. Also, the median number of IFU recovered from the lungs of mice vaccinated with PmpC (72 × 10 6 ) or PmpH (61 × 10 6 ) was significantly less than from mice immunized with PBS (620 × 10 6 ; P < 0.05). As determined by the number of IFU, all Pmps elicited less protection than C. muridarum MOMP (0.078 × 10 6 IFU; P < 0.05). Conclusions: This is the first time PmpC has been shown to elicit cross-species protection against a respiratory challenge. Additional work with Pmps C, G and H is recommended to determine their ability to protect animal models against genital and ocular challenges.